Company registration number SC525012 (Scotland)
KILMARNOCK HEALTHCARE SCOTLAND LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026
PAGES FOR FILING WITH REGISTRAR
KILMARNOCK HEALTHCARE SCOTLAND LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 5
KILMARNOCK HEALTHCARE SCOTLAND LTD
BALANCE SHEET
AS AT 31 JANUARY 2026
31 January 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Intangible assets
3
35,128
Tangible assets
4
286,641
259,238
286,641
294,366
Current assets
Stocks
16,000
5,000
Debtors
5
755,601
667,430
Cash at bank and in hand
156,033
163,274
927,634
835,704
Creditors: amounts falling due within one year
6
(411,626)
(401,857)
Net current assets
516,008
433,847
Total assets less current liabilities
802,649
728,213
Provisions for liabilities
(18,421)
(23,167)
Net assets
784,228
705,046
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
784,128
704,946
Total equity
784,228
705,046
KILMARNOCK HEALTHCARE SCOTLAND LTD
BALANCE SHEET (CONTINUED)
AS AT 31 JANUARY 2026
31 January 2026
- 2 -
For the financial year ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved and signed by the director and authorised for issue on 17 June 2026
S Shafiq
Director
Company registration number SC525012 (Scotland)
KILMARNOCK HEALTHCARE SCOTLAND LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026
- 3 -
1
Accounting policies
Company information
Kilmarnock Healthcare Scotland Ltd is a private company limited by shares incorporated in Scotland. The registered office is 6th, Floor, Gordon Chambers 90 Mitchell Street, Glasgow, Scotland, G1 3NQ.
1.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
1.2
Revenue
Turnover represents invoiced dental services.
Revenue from the sale of goods is recognised at a point in time when control of the goods, including the significant risks and rewards of ownership, have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
Revenue from contracts for the provision of professional services is recognised over time by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.
1.3
Intangible fixed assets - goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2016, is being amortised evenly over its estimated useful life of ten years.
1.4
Tangible fixed assets
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Improvements to property
2% on a straight line basis
Plant and equipment
20% on a reducing balance basis
Fixtures and fittings
20% on a reducing balance basis
Computers
33% on a straight line basis
Motor vehicles
25% on a reducing balance basis
1.5
Stocks
Stocks and work in progress are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.
1.6
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
KILMARNOCK HEALTHCARE SCOTLAND LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
1
Accounting policies
(Continued)
- 4 -
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2026
2025
Number
Number
Total
17
15
3
Intangible fixed assets
Goodwill
£
Cost
At 1 February 2025 and 31 January 2026
351,280
Amortisation and impairment
At 1 February 2025
316,152
Amortisation charged for the year
35,128
At 31 January 2026
351,280
Carrying amount
At 31 January 2026
At 31 January 2025
35,128
KILMARNOCK HEALTHCARE SCOTLAND LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 5 -
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 February 2025
195,234
315,865
511,099
Additions
66,394
66,394
At 31 January 2026
195,234
382,259
577,493
Depreciation and impairment
At 1 February 2025
28,666
223,195
251,861
Depreciation charged in the year
3,905
35,086
38,991
At 31 January 2026
32,571
258,281
290,852
Carrying amount
At 31 January 2026
162,663
123,978
286,641
At 31 January 2025
166,568
92,670
259,238
5
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
64,462
76,392
Other debtors
691,139
591,038
755,601
667,430
6
Creditors: amounts falling due within one year
2026
2025
£
£
Trade creditors
99,867
98,814
Taxation and social security
83,213
121,838
Other creditors
228,546
181,205
411,626
401,857
7
Related Party Disclosures
At 31 January 2026, the company was owed £592,990 by Companies under common directorship (2025: £577,710).
At 31 January 2026, the company owed £45,000 to Companies under common directorship (2025: £45,000).